Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | ...

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

Novartis CEO Vas Narasimhan received a total of 19.1 million Swiss Francs — or $21.4 million — in total compensation in 2024. This marked a 40% increase from his $15.3 million total compensation in ...

Vasant Narasimhan took over as CEO of Novartis, one of the world’s largest pharmaceutical companies, in 2018. Originally from Pittsburgh, Narasimhan attended the University of Chicago and ...

In February, The Wall Street Journal reported that Novartis CEO Vas Narasimhan was taking a highly selective approach toward potential acquisitions in the obesity treatment sector. The firm is ...

At Novartis, CEO Vas Narasimhan’s overall 2024 pay increased by 6.9% at grant value, reaching 14.2 million Swiss francs ($15.7 million), according to the company’s annual report (PDF).

CEO Vas Narasimhan pointed out during the Q4 2024 Earnings Call that if these yield positive results, Cosentyx would have further growth engines for the rest of this decade. Additionally ...

In response, Novartis CEO Vas Narasimhan, M.D., said, “We’ve had to give the appropriate level of adjustments on our rebates, but we've maintained [a] very good formulary position,” adding ...

CEO Vas Narasimhan said after its earnings call last week that the drugmaker had done 30 such deals in the past year. The Trump administration’s sudden freeze on funds to USAID has caused ...

Based in Bengaluru, Narasimhan as the Executive Committee member will lead their HR, Training & Knowledge Management (TKM), Corporate Services and Compliance teams. He will lead efforts in the ...

The company says it conducted a thorough evaluation of internal and external candidates, but decided that Vasant Narasimhan, known as Vas, was the best candidate to take the company forward.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.